The cost of morbidity of therapy should not outweigh the benefits. In patients with unilateral, low grade, focal prostate cancers, who are uncomfortable with active surveillance, or conversely with aggressive surgery, we now can offer the first truly focal prostate cancer cure by only treating the affected region.
If cancer shows up on the contralateral side in the future, a second focal freeze therapy can be applied. This allows the erectile nerves on the treated side time to recovery (takes 6-24 months). Thus offering cancer-control while incurring minimal morbidity. The idea of freezing seems more acceptable to patients than the thoughts of cutting, burning, radiating, or poisoning. Patients must feel comfortable with their treatment options. Studies have shown, patients’ confidence in their choice of therapy and healer, plays a powerful role in their recovery.